Literature DB >> 33202354

Unlocking the next generation of phage therapy: the key is in the receptors.

Fernando L Gordillo Altamirano1, Jeremy J Barr2.   

Abstract

Phage therapy, the clinical use of viruses that kill bacteria, is a promising strategy in the fight against antimicrobial resistance. Before administration, phages undergo a careful examination of their safety and interactions with target bacteria. This characterization seldom includes identifying the receptor on the bacterial surface involved in phage adsorption. In this perspective article, we propose that understanding the function and location of these phage receptors can open the door to improved and innovative ways to use phage therapy. With knowledge of phage receptors, we can design intelligent phage cocktails, discover new phage-derived antimicrobials, and steer the evolution of phage-resistance towards clinically exploitable phenotypes. In an effort to jump-start this initiative, we recommend priority groups of hosts and phages. Finally, we review modern approaches for the identification of phage receptors, including molecular platforms for high-throughput mutagenesis, synthetic biology, and machine learning.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Year:  2020        PMID: 33202354     DOI: 10.1016/j.copbio.2020.10.002

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  18 in total

1.  Systematic exploration of Escherichia coli phage-host interactions with the BASEL phage collection.

Authors:  Enea Maffei; Aisylu Shaidullina; Marco Burkolter; Yannik Heyer; Fabienne Estermann; Valentin Druelle; Patrick Sauer; Luc Willi; Sarah Michaelis; Hubert Hilbi; David S Thaler; Alexander Harms
Journal:  PLoS Biol       Date:  2021-11-16       Impact factor: 8.029

2.  Characterization of Pseudomonas aeruginosa Bacteriophage L5 Which Requires Type IV Pili for Infection.

Authors:  Lan Yang; Tingting Zhang; Linlin Li; Chao Zheng; Demeng Tan; Nannan Wu; Mingyang Wang; Tongyu Zhu
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

3.  Bacteriophage-Resistant Mutant of Enterococcus faecalis Is Impaired in Biofilm Formation.

Authors:  Jiazhen Liu; Yanpeng Zhu; Yang Li; Yuwen Lu; Kun Xiong; Qiu Zhong; Jing Wang
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

4.  Isolation and Characterisation of Bacteriophage Selective for Key Acinetobacter baumannii Capsule Chemotypes.

Authors:  Rosesathorn Soontarach; Potjanee Srimanote; Mark C Enright; George Blundell-Hunter; Matthew J Dorman; Nicholas R Thomson; Peter W Taylor; Supayang P Voravuthikunchai
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-02

Review 5.  Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections.

Authors:  Shizhou Wu; Binjie Wu; Yunjie Liu; Shu Deng; Lei Lei; Hui Zhang
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

6.  Involvement of a Phage-Encoded Wzy Protein in the Polymerization of K127 Units To Form the Capsular Polysaccharide of Acinetobacter baumannii Isolate 36-1454.

Authors:  Ruth M Hall; Yuriy A Knirel; Johanna J Kenyon; Nikolay P Arbatsky; Anastasiya A Kasimova; Alexander S Shashkov; Mikhail M Shneider; Anastasiya V Popova; Dmitry A Shagin; Andrey A Shelenkov; Yuliya V Mikhailova; Yurii G Yanushevich
Journal:  Microbiol Spectr       Date:  2022-04-27

7.  Efficacy of Individual Bacteriophages Does Not Predict Efficacy of Bacteriophage Cocktails for Control of Escherichia coli O157.

Authors:  Yan D Niu; Hui Liu; Hechao Du; Ruiqiang Meng; El Sayed Mahmoud; Guihua Wang; Tim A McAllister; Kim Stanford
Journal:  Front Microbiol       Date:  2021-02-24       Impact factor: 5.640

Review 8.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

Review 9.  The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia.

Authors:  Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Viruses       Date:  2021-06-03       Impact factor: 5.048

10.  Grand Challenges in Phage Biology.

Authors:  Sangryeol Ryu
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.